Key information to disclose includes: Medication name and dose "I take Wegovy (semaglutide) 2.4 mg once weekly by subcutaneous injection" Duration of treatment how long you have been taking Wegovy and whether you are still in the dose-escalation phase Current side effects any ongoing nausea, vomiting, diarrhoea, dizziness, or other symptoms Reason for prescription whether prescribed for obesity alone or with comorbidities such as type 2 diabetes, hypertension, or cardiovascular disease Overall health status current weight, blood pressure, and general wellbeing Donation staff will ask about your medical history and may need to consult with medical advisors regarding Wegovy
Brookshire: Things in the gastrointestinal tract get broken down really, really fast, and so
Khloe who is predisposed to the skin cancer is asked about the 'band-aid on you face' by Scott during their hangout with Kim
During power outages or refrigerator malfunctions, patients should contact their pharmacist or the medication manufacturer for guidance on temperature excursions
But there are specific situations where under-eating on a GLP-1 has moved beyond a manageable inconvenience and into territory that warrants a medical conversation without delay